
    
      The following agents will be studied:

      Etravirine, Intelence, TMC125; Emtricitabine, Emtriva or FTC; Tenofovir, Viread, TDF;
      Atazanavir, Reyataz; Fosamprenavir, Telzir, FPV; Darunavir, Prezista, TMC114; Tipranavir,
      Aptivus, TPV; Indinavir, Crixivan; abacavir; raltegravir, Isentress; Enfuvirtide, Fuzeon;
      Maraviroc, Celsentri; dolutegravir; elvitegravir/cobicistat; rilpivirine, TAF,
      darunavir/cobicistat; doravirine; bictegravir
    
  